Mechanism of the protective effects of prostaglandins E1 and F2 alpha in canine endotoxin shock.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002403:Cathepsins / Q000097:blood; D002496:Central Venous Pressure / Q000187:drug effects; D004285:Dogs; D004926:Escherichia coli; D005966:Glucuronidase / Q000097:blood; D006339:Heart Rate / Q000187:drug effects; D008099:Liver / Q000166:cytology; D008247:Lysosomes / Q000187:drug effects / Q000201:enzymology; D010179:Pancreas / Q000166:cytology; D010447:Peptide Hydrolases / Q000378:metabolism; D010455:Peptides / Q000097:blood; D011453:Prostaglandins / Q000494:pharmacology / Q000627:therapeutic use*; D012772:Shock, Septic / Q000188:drug therapy*; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D010455:Peptides; D011453:Prostaglandins; D005966:Glucuronidase; D002403:Cathepsins; D010447:Peptide Hydrolases